Seres Therapeutics, Inc.

Seres

We are a microbiome therapeutics platform company developing a novel class of biological drugs, which we refer to as Ecobiotic microbiome therapeutics. The human microbiome is an ecology of microorganisms, including bacteria, fungi and viruses, that, when unhealthy, or dysbiotic, can leave the body more susceptible to infections, metabolic disorders, allergies, autoimmune disease, inflammation and other serious conditions. Our drugs are designed to restore health by repairing the function of a dysbiotic microbiome. We are initially focused on implementing our microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome, one of the most diverse microbiomes in the human body.

Salaries

3 salaries reported
$98,221 per year
Min and max salaries are hidden when we have fewer than 5 salaries

About Seres Therapeutics, Inc.

Mission Statement
Our mission is to transform the lives of patients worldwide with revolutionary microbiome-based therapeutics.

Seres Therapeutics is creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis
New insights into the human microbiome are fundamentally
 – more... 

Claimed Profile
Headquarters
215 First Street, Suite 100
Cambridge, MA 02142
Revenue
less than $1M (USD)
Employees
51 to 200
Industry
Links
Seres Therapeutics, Inc. website